Our findings reveal the biological significance of the conserved TMEM217–SLC9C1 interaction and give insights into the diagnosis and therapeutic strategy of asthenozoospermia associated with defective cAMP signaling. The gene discussed is SLC9C1; the disease is Reduced sperm motility.